EP3182844B1 - Method for reducing the amount of tobacco specific nitrosamines in liquids containing nicotine - Google Patents

Method for reducing the amount of tobacco specific nitrosamines in liquids containing nicotine Download PDF

Info

Publication number
EP3182844B1
EP3182844B1 EP15753036.1A EP15753036A EP3182844B1 EP 3182844 B1 EP3182844 B1 EP 3182844B1 EP 15753036 A EP15753036 A EP 15753036A EP 3182844 B1 EP3182844 B1 EP 3182844B1
Authority
EP
European Patent Office
Prior art keywords
tobacco
nanometres
slurry
amount
tobacco slurry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP15753036.1A
Other languages
German (de)
French (fr)
Other versions
EP3182844A2 (en
Inventor
Gerhard Lang
Jan Carlos HUFNAGEL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philip Morris Products SA
Original Assignee
Philip Morris Products SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris Products SA filed Critical Philip Morris Products SA
Priority to PL15753036T priority Critical patent/PL3182844T3/en
Publication of EP3182844A2 publication Critical patent/EP3182844A2/en
Application granted granted Critical
Publication of EP3182844B1 publication Critical patent/EP3182844B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/22Treatment of tobacco products or tobacco substitutes by application of electric or wave energy or particle radiation
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/24Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241Extraction of specific substances
    • A24B15/243Nicotine
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/24Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241Extraction of specific substances
    • A24B15/245Nitrosamines
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10Devices using liquid inhalable precursors

Definitions

  • the present invention relates to methods of forming aerosol-generating substrates having a reduced amount of tobacco-specific nitrosamines.
  • the aerosol-generating substrates formed according to the present invention find particular application as substrates for electrical smoking systems.
  • a known electrically operated smoking system comprises a shell and a replaceable mouthpiece wherein the shell comprises an electric power supply and electric circuitry.
  • the mouthpiece comprises a liquid storage portion, a capillary wick having a first end that extends into the liquid storage portion for contact with liquid therein, and a heating element for heating a second end of the capillary wick.
  • liquid is transferred from the liquid storage portion towards the heating element by capillary action in the wick. Liquid at the second end of the wick is vaporised by the heating element.
  • a known electrically operated smoking system comprises a resistively heated ceramic heater blade that is inserted into a tobacco rod to generate an aerosol comprising volatile compounds contained within the tobacco.
  • Cast leaf tobacco products are formed by casting and drying a tobacco slurry.
  • Liquid nicotine formulations and tobacco slurries are typically derived from cured tobacco materials.
  • liquid nicotine formulations and heated tobacco products formed from tobacco slurries may be undesirably contaminated with tobacco-specific nitrosamines (TSNAs), such as N -nitrosonornicotine (NNN), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), N- nitrosoanatabine (NAT) and N-Nitrosoanabasine (NAB).
  • TSNAs tobacco-specific nitrosamines
  • NNN N -nitrosonornicotine
  • NNK 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
  • NAT N- nitrosoanatabine
  • NAB N-Nitrosoanabasine
  • WO 01/65954 A1 describes a process of treating tobacco to reduce or eliminate nitrosamines therefrom, the process comprising the use of a supercritical fluid extraction medium to remove nitrosamines from the tobacco.
  • the supercritical fluid extraction medium is irradiated with UV light before the supercritical fluid extraction medium is cycled back through the tobacco.
  • the use of a supercritical fluid extraction medium to remove nitrosamines from the tobacco is both costly and complex.
  • WO02/13636 discloses the UV treatment of tobacco leaves before or during curing in order to reduce the amount of TSNA-s, which is according to the teachings formed by exclusively bacterial activity.
  • US1754117 discloses that the UV treatment of cured tobacco will result in the reduction or neutralisation of the poisonous effects of nicotine.
  • CN101828763 discloses the UV treatment of cut and dried tobacco stems to improve the cut stem quality.
  • Another known method for reducing TSNA contamination of nicotine purified from cured tobacco materials includes chemical treatment of the tobacco plants prior to harvest to increase antioxidant production and prevent TSNA formation during curing.
  • the process of treating the tobacco plants is time consuming, costly, and care must be taken to prevent environmental contamination with the chemicals used.
  • a method for reducing the amount of at least one tobacco-specific nitrosamine in an aerosol-generating substrate comprising providing a tobacco slurry containing at least one tobacco-specific nitrosamine, irradiating the tobacco slurry with ultraviolet light, and drying the tobacco slurry to form an aerosol-generating substrate.
  • aerosol-generating substrate refers to a substrate capable of releasing volatile compounds, which can form an aerosol.
  • the aerosols generated from aerosol-generating substrates according to the invention may be visible or invisible and may include vapours (for example, fine particles of substances, which are in a gaseous state, that are ordinarily liquid or solid at room temperature) as well as gases and liquid droplets of condensed vapours.
  • the method according to the present invention advantageously eliminates the need for chemical removal processes.
  • the method according to the present invention may therefore be cheaper, produce little or no waste, and minimise any health and environmental concerns when compared to existing processes.
  • the present invention utilises UV irradiation of a tobacco slurry it can be applied to tobacco plant material that has already been harvested and processed. This is in contrast to known methods, such as the chemical treatment method described above that requires treatment of the tobacco plant during cultivation and prior to harvest, and other known methods that attempt to reduce TSNA content by optimising the conditions under which the harvested tobacco is cured.
  • the tobacco slurry may be cast and dried to form a cast leaf tobacco.
  • the tobacco slurry may be irradiated before casting, after casting, or both.
  • Such a method may be advantageous in that it would allow for integration of an apparatus capable of irradiating the slurry directly into a casting line.
  • the term "cast leaf tobacco” refers to a homogenised tobacco material typically formed by casting a tobacco slurry comprising particulate tobacco and one or more binders onto a conveyor belt or other surface, drying the cast slurry to form a sheet of homogenised tobacco material and removing the sheet of homogenised tobacco material from the support surface.
  • the ultraviolet irradiance of the tobacco slurry is preferably at least about 4 milliwatts per square centimetre, more preferably at least about 40 milliwatts per square centimetre, most preferably at least about 400 milliwatts per square centimetre.
  • UV irradiance at or above these levels can provide significant reduction of the amount of the one or more TSNAs within a relatively short time period.
  • the irradiation level of a fluid can be determined using a UV radiometer.
  • the UV irradiance step preferably comprises irradiating the tobacco slurry with ultraviolet light for less than about 180 minutes, more preferably less than about 120 minutes, yet more preferably less than about 60 minutes, most preferably less than about 30 minutes. Irradiating the tobacco slurry with ultraviolet light for a period within these ranges can provide significant reduction in the amount of the one or more TSNAs.
  • These time periods refer to the total duration of the UV irradiation and the total duration may be a single consecutive period of irradiance, or two or more discrete periods of irradiance.
  • the irradiance may be conducted in a single 30 minute step, or in two separate steps each of 15 minutes long.
  • the total irradiation time may be varied according to the thickness of the tobacco slurry. That is, the total irradiation time may be increased as the thickness of the tobacco slurry is increased.
  • a high UV irradiance is preferably used to minimise the total time required to reduce the TSNA content to a desired level.
  • the amount of the at least one tobacco-specific nitrosamine present in the tobacco slurry after the irradiation step is preferably less than about 75 percent by weight of the amount of the at least one tobacco-specific nitrosamine present in the tobacco slurry before the irradiation step, more preferably less than about 50 percent by weight of the amount of the at least one tobacco-specific nitrosamine present in the tobacco slurry before the irradiation step, most preferably less than about 25 percent by weight of the amount of the at least one tobacco-specific nitrosamine present in the tobacco slurry before the irradiation step.
  • the reduction in the amount of the at least one tobacco-specific nitrosamine can be increased by increasing at least one of the irradiance and the duration of the irradiating step.
  • the amount of the at least one tobacco-specific nitrosamine present in the tobacco slurry decreases in a generally exponential manner during the period of irradiation.
  • the ultraviolet light used in the irradiating step preferably has a peak intensity at a wavelength of at least about 315 nanometres, more preferably at least about 335 nanometres, most preferably at least about 350 nanometres. Additionally, or alternatively, the ultraviolet light preferably has a peak intensity at a wavelength of less than about 400 nanometres, more preferably less than about 390 nanometres, most preferably less than about 380 nanometres. In particularly preferred embodiments, the ultraviolet light has a peak intensity at a wavelength of between about 315 nanometres and about 400 nanometres, more preferably between about 335 nanometres and about 390 nanometres, most preferably between about 350 nanometres and about 380 nanometres.
  • the ultraviolet light may have a peak intensity at a wavelength of about 365 nanometres. UV light having a peak intensity at a wavelength within these ranges falls within the UV-A portion of the ultraviolet spectrum, which the present inventors have recognised provides effective reduction of TSNAs and is optimised for transmission through glass and common UV transparent polymeric packaging materials. Therefore, methods in accordance with these embodiments are particularly suited for the treatment of aerosol-generating substrates or tobacco slurries that are housed within a glass container, or housed within a container comprising a glass window through which the UV light is transmitted. Use of radiation having a shorter wavelength is undesirable, as it may result in undesirable chemical decomposition of the nicotine.
  • N-nitrosonornicotine N-nitrosonornicotine
  • NNK 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
  • the UV irradiation caused a time-dependent decrease of NNK and NNN in all three nicotine/glycerin/propylene-glycol/water mixtures. Nicotine concentrations were not affected. The nitrosamine decay is approximately exponential with respect to irradiation time. Half-lives for NNN and NNK were in the ranges of 30-50 minutes and 60-70 minutes, respectively. The results are illustrated in Figures 1 to 3 .
  • a sample sheet of cast tobacco slurry having a thickness of 0.20 to 0.22 millimetres after drying to 195 to 200 grams per square metre was irradiated for 150 minutes, each, on both sides with UV light at a wavelength of 365 nanometres and an intensity of 4.5 milliwatts per square centimetre.
  • the irradiated cast leaf sample and a non-irradiated control were analysed for NNK, NNN, and nicotine content by mass spectroscopy. As compared to the control, the irradiated sample indicated no effect on nicotine content, a reduction of 12 percent in NNK content, and a reduction of 26 percent in NNN content.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)

Description

  • The present invention relates to methods of forming aerosol-generating substrates having a reduced amount of tobacco-specific nitrosamines. The aerosol-generating substrates formed according to the present invention find particular application as substrates for electrical smoking systems.
  • Electrically operated smoking systems that vaporise a liquid nicotine formulation to form an aerosol that is inhaled by a user are known in the art. For example, a known electrically operated smoking system comprises a shell and a replaceable mouthpiece wherein the shell comprises an electric power supply and electric circuitry. The mouthpiece comprises a liquid storage portion, a capillary wick having a first end that extends into the liquid storage portion for contact with liquid therein, and a heating element for heating a second end of the capillary wick. In use, liquid is transferred from the liquid storage portion towards the heating element by capillary action in the wick. Liquid at the second end of the wick is vaporised by the heating element.
  • Electrically operated smoking systems that heat a tobacco product, such as a cast leaf tobacco product, are also known. For example, a known electrically operated smoking system comprises a resistively heated ceramic heater blade that is inserted into a tobacco rod to generate an aerosol comprising volatile compounds contained within the tobacco. Cast leaf tobacco products are formed by casting and drying a tobacco slurry.
  • Liquid nicotine formulations and tobacco slurries are typically derived from cured tobacco materials. As such, liquid nicotine formulations and heated tobacco products formed from tobacco slurries may be undesirably contaminated with tobacco-specific nitrosamines (TSNAs), such as N-nitrosonornicotine (NNN), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), N-nitrosoanatabine (NAT) and N-Nitrosoanabasine (NAB).
  • WO 01/65954 A1 describes a process of treating tobacco to reduce or eliminate nitrosamines therefrom, the process comprising the use of a supercritical fluid extraction medium to remove nitrosamines from the tobacco. In some embodiments, the supercritical fluid extraction medium is irradiated with UV light before the supercritical fluid extraction medium is cycled back through the tobacco. However, the use of a supercritical fluid extraction medium to remove nitrosamines from the tobacco is both costly and complex. WO02/13636 discloses the UV treatment of tobacco leaves before or during curing in order to reduce the amount of TSNA-s, which is according to the teachings formed by exclusively bacterial activity. US1754117 discloses that the UV treatment of cured tobacco will result in the reduction or neutralisation of the poisonous effects of nicotine. CN101828763 discloses the UV treatment of cut and dried tobacco stems to improve the cut stem quality. Another known method for reducing TSNA contamination of nicotine purified from cured tobacco materials includes chemical treatment of the tobacco plants prior to harvest to increase antioxidant production and prevent TSNA formation during curing. However, the process of treating the tobacco plants is time consuming, costly, and care must be taken to prevent environmental contamination with the chemicals used.
  • It would therefore be desirable to provide a method of reducing or eliminating TSNA contamination of nicotine that overcomes these difficulties associated with known methods of TSNA reduction.
  • According to the present invention there is provided a method for reducing the amount of at least one tobacco-specific nitrosamine in an aerosol-generating substrate, the method comprising providing a tobacco slurry containing at least one tobacco-specific nitrosamine, irradiating the tobacco slurry with ultraviolet light, and drying the tobacco slurry to form an aerosol-generating substrate.
  • As used herein, the term "aerosol-generating substrate" refers to a substrate capable of releasing volatile compounds, which can form an aerosol. The aerosols generated from aerosol-generating substrates according to the invention may be visible or invisible and may include vapours (for example, fine particles of substances, which are in a gaseous state, that are ordinarily liquid or solid at room temperature) as well as gases and liquid droplets of condensed vapours.
  • By using ultraviolet (UV) light to reduce the amount of one or more TSNAs in an aerosol-generating substrate formed from a tobacco slurry, the method according to the present invention advantageously eliminates the need for chemical removal processes. The method according to the present invention may therefore be cheaper, produce little or no waste, and minimise any health and environmental concerns when compared to existing processes. Furthermore, since the present invention utilises UV irradiation of a tobacco slurry it can be applied to tobacco plant material that has already been harvested and processed. This is in contrast to known methods, such as the chemical treatment method described above that requires treatment of the tobacco plant during cultivation and prior to harvest, and other known methods that attempt to reduce TSNA content by optimising the conditions under which the harvested tobacco is cured.
  • The tobacco slurry may be cast and dried to form a cast leaf tobacco. In this case, the tobacco slurry may be irradiated before casting, after casting, or both. Such a method may be advantageous in that it would allow for integration of an apparatus capable of irradiating the slurry directly into a casting line.
  • As used herein, the term "cast leaf tobacco" refers to a homogenised tobacco material typically formed by casting a tobacco slurry comprising particulate tobacco and one or more binders onto a conveyor belt or other surface, drying the cast slurry to form a sheet of homogenised tobacco material and removing the sheet of homogenised tobacco material from the support surface.
  • In any of the embodiments described above, the ultraviolet irradiance of the tobacco slurry is preferably at least about 4 milliwatts per square centimetre, more preferably at least about 40 milliwatts per square centimetre, most preferably at least about 400 milliwatts per square centimetre. UV irradiance at or above these levels can provide significant reduction of the amount of the one or more TSNAs within a relatively short time period. The irradiation level of a fluid can be determined using a UV radiometer.
  • Additionally, or alternatively, the UV irradiance step preferably comprises irradiating the tobacco slurry with ultraviolet light for less than about 180 minutes, more preferably less than about 120 minutes, yet more preferably less than about 60 minutes, most preferably less than about 30 minutes. Irradiating the tobacco slurry with ultraviolet light for a period within these ranges can provide significant reduction in the amount of the one or more TSNAs. These time periods refer to the total duration of the UV irradiation and the total duration may be a single consecutive period of irradiance, or two or more discrete periods of irradiance. For example, in those embodiments in which the irradiating step comprises irradiating the tobacco slurry with UV light for 30 minutes, the irradiance may be conducted in a single 30 minute step, or in two separate steps each of 15 minutes long. The total irradiation time may be varied according to the thickness of the tobacco slurry. That is, the total irradiation time may be increased as the thickness of the tobacco slurry is increased.
  • Generally, increasing the UV irradiance will yield a higher reduction in TSNA content over a fixed time period. Therefore, to optimise the efficiency of the TSNA reduction process, a high UV irradiance is preferably used to minimise the total time required to reduce the TSNA content to a desired level. In any of the embodiments described above, the amount of the at least one tobacco-specific nitrosamine present in the tobacco slurry after the irradiation step is preferably less than about 75 percent by weight of the amount of the at least one tobacco-specific nitrosamine present in the tobacco slurry before the irradiation step, more preferably less than about 50 percent by weight of the amount of the at least one tobacco-specific nitrosamine present in the tobacco slurry before the irradiation step, most preferably less than about 25 percent by weight of the amount of the at least one tobacco-specific nitrosamine present in the tobacco slurry before the irradiation step. Generally, the reduction in the amount of the at least one tobacco-specific nitrosamine can be increased by increasing at least one of the irradiance and the duration of the irradiating step. For a given irradiance, the amount of the at least one tobacco-specific nitrosamine present in the tobacco slurry decreases in a generally exponential manner during the period of irradiation.
  • In any of the embodiments described above, the ultraviolet light used in the irradiating step preferably has a peak intensity at a wavelength of at least about 315 nanometres, more preferably at least about 335 nanometres, most preferably at least about 350 nanometres. Additionally, or alternatively, the ultraviolet light preferably has a peak intensity at a wavelength of less than about 400 nanometres, more preferably less than about 390 nanometres, most preferably less than about 380 nanometres. In particularly preferred embodiments, the ultraviolet light has a peak intensity at a wavelength of between about 315 nanometres and about 400 nanometres, more preferably between about 335 nanometres and about 390 nanometres, most preferably between about 350 nanometres and about 380 nanometres. The ultraviolet light may have a peak intensity at a wavelength of about 365 nanometres. UV light having a peak intensity at a wavelength within these ranges falls within the UV-A portion of the ultraviolet spectrum, which the present inventors have recognised provides effective reduction of TSNAs and is optimised for transmission through glass and common UV transparent polymeric packaging materials. Therefore, methods in accordance with these embodiments are particularly suited for the treatment of aerosol-generating substrates or tobacco slurries that are housed within a glass container, or housed within a container comprising a glass window through which the UV light is transmitted. Use of radiation having a shorter wavelength is undesirable, as it may result in undesirable chemical decomposition of the nicotine.
  • Example 1
  • Defined concentrations of N-nitrosonornicotine (NNN) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) (380 and 613 nanograms per millilitre, respectively) were added to three different liquid aerosol-generating substrates each consisting of nicotine, glycerin, propylene glycol and water (2:10:68:20, 2:39:39:20 and 2:68:10:20 by weight). Aliquots of these solutions were placed in clear glass vials and irradiated for a specified time (0, 15, 30, 60, 120 or 240 minutes) with ultraviolet radiation (wavelength of 365 nanometres; lamp nominal power of 8 watts; distance to lamp of 3 centimetres). After irradiation the samples were diluted ten-fold with water and their nicotine, NNN and NNK content was analyzed.
  • The UV irradiation caused a time-dependent decrease of NNK and NNN in all three nicotine/glycerin/propylene-glycol/water mixtures. Nicotine concentrations were not affected. The nitrosamine decay is approximately exponential with respect to irradiation time. Half-lives for NNN and NNK were in the ranges of 30-50 minutes and 60-70 minutes, respectively. The results are illustrated in Figures 1 to 3.
  • Example 2
  • A sample sheet of cast tobacco slurry having a thickness of 0.20 to 0.22 millimetres after drying to 195 to 200 grams per square metre was irradiated for 150 minutes, each, on both sides with UV light at a wavelength of 365 nanometres and an intensity of 4.5 milliwatts per square centimetre. After further drying and cutting, the irradiated cast leaf sample and a non-irradiated control were analysed for NNK, NNN, and nicotine content by mass spectroscopy. As compared to the control, the irradiated sample indicated no effect on nicotine content, a reduction of 12 percent in NNK content, and a reduction of 26 percent in NNN content.

Claims (6)

  1. A method for reducing the amount of at least one tobacco-specific nitrosamine in an aerosol-generating substrate, the method comprising:
    providing a tobacco slurry containing the at least one tobacco-specific nitrosamine;
    irradiating the tobacco slurry with ultraviolet light; and
    drying the tobacco slurry to form an aerosol-generating substrate.
  2. A method according to claim 1, further comprising a step of casting the tobacco slurry before the step of drying the tobacco slurry, and wherein the step of casting the tobacco slurry is performed before or after the step of irradiating the tobacco slurry.
  3. A method according to claim 1 or 2, wherein the ultraviolet irradiance of the tobacco slurry is at least 4 milliwatts per square centimetre.
  4. A method according to claim 1, 2 or 3, wherein the tobacco slurry is irradiated with ultraviolet light for less than 60 minutes.
  5. A method according to any preceding claim, wherein the ultraviolet light has a peak intensity at a wavelength of between 315 nanometres and 400 nanometres.
  6. A method according to any preceding claim, wherein the ultraviolet light has a peak intensity at a wavelength of between 350 nanometres and 380 nanometres.
EP15753036.1A 2014-08-20 2015-08-19 Method for reducing the amount of tobacco specific nitrosamines in liquids containing nicotine Active EP3182844B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL15753036T PL3182844T3 (en) 2014-08-20 2015-08-19 Method for reducing the amount of tobacco specific nitrosamines in liquids containing nicotine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14181679 2014-08-20
PCT/EP2015/069091 WO2016026911A2 (en) 2014-08-20 2015-08-19 Methods for forming aerosol-generating substrates having a reduced amount of tobacco specific nitrosamines

Publications (2)

Publication Number Publication Date
EP3182844A2 EP3182844A2 (en) 2017-06-28
EP3182844B1 true EP3182844B1 (en) 2018-08-15

Family

ID=51357871

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15753036.1A Active EP3182844B1 (en) 2014-08-20 2015-08-19 Method for reducing the amount of tobacco specific nitrosamines in liquids containing nicotine

Country Status (11)

Country Link
US (1) US20170238597A1 (en)
EP (1) EP3182844B1 (en)
JP (1) JP6602845B2 (en)
KR (1) KR102486705B1 (en)
CN (1) CN106714587B (en)
BR (1) BR112017001255B1 (en)
ES (1) ES2690876T3 (en)
HU (1) HUE040016T2 (en)
PL (1) PL3182844T3 (en)
RU (1) RU2685845C2 (en)
WO (1) WO2016026911A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201504587D0 (en) * 2015-03-18 2015-05-06 British American Tobacco Co Improvements in methods of treating tobacco.
WO2024062588A1 (en) * 2022-09-22 2024-03-28 日本たばこ産業株式会社 Decolored tobacco material and method for manufacturing same

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB333826A (en) * 1928-11-09 1930-08-21 Georg Senftner Process and means for the preservation of the aroma of tobacco and tobacco goods
US1754117A (en) * 1929-05-03 1930-04-08 Charles M Richter Method of reducing the poisonous effects of nicotine and the product thereof
US3472237A (en) * 1967-05-24 1969-10-14 Steber Corp Irradiated tobacco process and product
US5007440A (en) * 1989-11-14 1991-04-16 R. J. Reynolds Tobacco Company Process for providing smokable material
US5327917A (en) * 1990-08-15 1994-07-12 R. J. Reynolds Tobacco Company Method for providing a reconstituted tobacco material
US6202649B1 (en) * 1996-12-02 2001-03-20 Regent Court Technologies Method of treating tobacco to reduce nitrosamine content, and products produced thereby
US6058940A (en) * 1997-04-21 2000-05-09 Lane; Kerry Scott Method and system for assay and removal of harmful toxins during processing of tobacco products
GEP20022696B (en) * 1997-06-20 2002-05-27 Regent Court Tech Method of Reduce Nitrosamine Content of and Preventing Formation of Carcinogenic Nitrosamines in Harvested Leafy Plants, Tobacco Products and Products Produced Thereby
CA2400408C (en) * 2000-03-10 2008-12-30 British American Tobacco (Investments) Limited Tobacco treatment
WO2002013636A1 (en) * 2000-08-11 2002-02-21 Philip Morris Products Inc. A method and apparatus for reducing tobacco specific nitrosamines
US6564808B1 (en) * 2000-08-11 2003-05-20 Philip Morris Incorporated Method for reduction of tobacco specific nitrosamines
ES2535285T3 (en) 2000-10-05 2015-05-07 Schweitzer-Mauduit International, Inc. Reduction of nitrosamines in tobacco and tobacco products
US20050039767A1 (en) * 2002-11-19 2005-02-24 John-Paul Mua Reconstituted tobacco sheet and smoking article therefrom
UA79698C2 (en) * 2003-05-06 2007-07-10 Japan Tobacco Inc Method for making regenerated tobacco material
DE10326496B4 (en) * 2003-06-10 2005-11-10 Reemtsma Cigarettenfabriken Gmbh Tobacco mixture, as well as a cigarette containing them
US20060016125A1 (en) * 2004-07-23 2006-01-26 Philip Morris Usa Inc. Light treatment for reduction of tobacco specific nitrosamines
CA2702222C (en) * 2007-10-11 2016-08-30 Richard Fuisz Smokeless tobacco product
CN201550591U (en) * 2009-10-27 2010-08-18 广东中烟工业有限责任公司 Preparation system for tobacco sheets
CN201577521U (en) * 2009-12-22 2010-09-15 湖北中烟工业有限责任公司 Paper-making method thin plate crinkle shaping device
CN101744357B (en) * 2009-12-23 2011-10-12 湖南中烟工业有限责任公司 Method for solid-liquid separation during sheet production through papermaking process
CN101797070B (en) * 2010-03-01 2012-08-01 山东中烟工业公司 Ammonium salt-containing tobacco leaf reproduced by means of rolling
CN101828763B (en) * 2010-04-30 2013-01-02 河南农业大学 Method for improving cut stem quality by using combination of ultraviolet radiation and steam explosion
CN101904558B (en) * 2010-07-23 2012-05-09 安徽中烟工业公司 Preparation method of rolled tobacco sheet
CN203709245U (en) * 2014-01-28 2014-07-16 江苏维尔电气有限公司 Tobacco sheet raw material pretreatment burdening and raw material pretreatment blending mixing system
CN103892440B (en) * 2014-03-07 2015-03-18 广东省金叶科技开发有限公司 Equipment for producing reconstituted tobacco through dry-method paper making method
CN103892437B (en) * 2014-03-28 2016-03-30 广东中烟工业有限责任公司 A kind of production method of novel tobacco goods

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
KR20170044092A (en) 2017-04-24
WO2016026911A2 (en) 2016-02-25
JP6602845B2 (en) 2019-11-06
KR102486705B1 (en) 2023-01-10
US20170238597A1 (en) 2017-08-24
RU2685845C2 (en) 2019-04-23
CN106714587B (en) 2021-10-22
WO2016026911A3 (en) 2016-04-21
PL3182844T3 (en) 2019-04-30
ES2690876T3 (en) 2018-11-22
BR112017001255B1 (en) 2021-12-21
JP2017525363A (en) 2017-09-07
HUE040016T2 (en) 2019-02-28
BR112017001255A2 (en) 2017-11-14
RU2017108898A3 (en) 2018-10-30
CN106714587A (en) 2017-05-24
EP3182844A2 (en) 2017-06-28
RU2017108898A (en) 2018-09-20

Similar Documents

Publication Publication Date Title
CN105142430B (en) Method for producing constituent element of luxury product containing fragrance component, and constituent element of luxury product containing fragrance component
EP3062641B1 (en) Tobacco material and treatment thereof
JP3931084B2 (en) Tobacco treatment method
US8651115B2 (en) Combination treatment of tobacco extract using antioxidants and antioxidant scavengers
CN106028844B (en) The manufacture method of the extracting method of fragranced composition and the inscape of preference
NO312325B1 (en) Process for the treatment of tobacco to reduce the content of nitrosamine and products thus produced
EP3062642B1 (en) Tobacco material and treatment thereof
EP3182844B1 (en) Method for reducing the amount of tobacco specific nitrosamines in liquids containing nicotine
KR101851091B1 (en) Smoking flavor component extraction method and luxury food item constituent- component manufacturing method
EP3270717A1 (en) Improvements in methods of treating tobacco
WO2022024307A1 (en) Method for extracting flavor component and method for producing constituent element of processed tobacco leaves
CN104939304A (en) Preparation and application methods of plant extract for lowering tobacco-specific nitrosamine content
WO2019130376A1 (en) Method for producing tobacco material, and smoking article containing tobacco material obtained using the production method
CZ9904636A3 (en) Tobacco treatment process

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20161222

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20180305

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HUFNAGEL, JAN CARLOS

Inventor name: LANG, GERHARD

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1028710

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180815

Ref country code: GB

Ref legal event code: FG4D

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 4

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: JACOBACCI AND PARTNERS SA, CH

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602015014863

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2690876

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20181122

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1028710

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180815

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181116

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181115

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181215

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

REG Reference to a national code

Ref country code: HU

Ref legal event code: AG4A

Ref document number: E040016

Country of ref document: HU

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180819

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20180831

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602015014863

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

26N No opposition filed

Effective date: 20190516

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180819

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180831

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180819

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180815

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180815

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230529

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20230817

Year of fee payment: 9

Ref country code: IT

Payment date: 20230822

Year of fee payment: 9

Ref country code: CH

Payment date: 20230902

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20230821

Year of fee payment: 9

Ref country code: HU

Payment date: 20230823

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20231027

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20240821

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BG

Payment date: 20240823

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240821

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240826

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240829

Year of fee payment: 10